Study Title
Neoadjuvant [177Lu]Lu-PSMAI&T Radioligand Therapy (PSMA-RLT) for Patients With Oligometastatic Prostate Cancer Diagnosed Using [68Ga]Ga-PSMA-11 PET Imaging Followed by Radical Prostatectomy: A Prospective Phase II Pilot Study
Study Details
Description:
Prospective single-center phase II study to evaluate the PSA, imaging and pathological response, as well as oncological outcomes of systemic radioligand therapy [177Lu]Lu-PSMAI&T (PSMA-RLT) in patients planned for radical prostatectomy (RP) for oligometastatic prostate cancer (PCa) diagnosed using [68Ga]Ga-PSMA-11 PET examination. Ten patients with oligometastatic primary PCa diagnosed using [68Ga]Ga-PSMA-11 PET-CT/MRI imaging will be included in this study.
Sponsor:
Medical University of Vienna
Contacts:
Sazan Rasul, PhD (Principal Investigator)sazan.rasul@meduniwien.ac.at
004314040058742
Shahrokh F. Shariat, Professorshahrokh.shariat@meduniwien.ac.at
004314040026150
Government Study Link:
NCT06259123 - Click here to see study onClinicalTrials.gov